{"id":62294,"date":"2026-04-03T16:47:20","date_gmt":"2026-04-03T08:47:20","guid":{"rendered":"https:\/\/flcube.com\/?p=62294"},"modified":"2026-04-03T16:47:21","modified_gmt":"2026-04-03T08:47:21","slug":"xellar-biosystems-closes-rmb-200m-series-a-led-by-china-life-investment-to-build-3d-bio-intelligence-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=62294","title":{"rendered":"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform"},"content":{"rendered":"\n<p><strong>Xellar Biosystems<\/strong>, a U.S.-based pioneer in <strong>\u201cAI + organ-on-a-chip\u201d<\/strong> technology, announced the successful completion of a <strong>Series A financing round exceeding RMB 200 million (\u2248 USD 29 million)<\/strong>. The round was <strong>exclusively led by China Life Investment<\/strong>, with continued backing from existing investors <strong>XtalPi<\/strong>, <strong>Yael Capital<\/strong>, and <strong>Legend Capital<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-funding-amp-strategic-allocation\">Funding &amp; Strategic Allocation<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Use of Proceeds<\/th><th>Key Initiatives<\/th><\/tr><\/thead><tbody><tr><td><strong>Next-Gen Biological Infrastructure<\/strong><\/td><td>Expand humanized <strong>organ-on-a-chip disease models<\/strong> across major therapeutic areas<\/td><\/tr><tr><td><strong>Mechanistic Research Platform<\/strong><\/td><td>Build a <strong>scalable, standardized system<\/strong> for high-throughput biological experimentation<\/td><\/tr><tr><td><strong>Real Biological Data Engine<\/strong><\/td><td>Continuously collect and curate <strong>high-fidelity, multimodal wet-lab data<\/strong> from 3D tissue models<\/td><\/tr><tr><td><strong>AI Integration<\/strong><\/td><td>Develop proprietary AI platform fusing <strong>computer vision<\/strong>, <strong>knowledge graphs<\/strong>, and <strong>multimodal modeling<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>The company aims to establish a self-reinforcing <strong>\u201cdata generation \u2192 mechanism analysis \u2192 model training \u2192 experimental validation\u201d flywheel<\/strong>, forming the core of its <strong>3D Bio Intelligence system<\/strong>\u2014a digital framework that combines <strong>real-world biological data<\/strong> with <strong>virtual cell simulations<\/strong> to dynamically represent and predict complex physiological and pathological processes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-vision\">Technology Vision<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Beyond 2D Models:<\/strong> Xellar\u2019s humanized organ chips replicate tissue architecture, mechanical cues, and multicellular interactions absent in traditional cell cultures.<\/li>\n\n\n\n<li><strong>Mechanism-First AI:<\/strong> Unlike black-box AI drug discovery firms, Xellar grounds its models in <strong>causal biological mechanisms<\/strong>, validated through iterative wet-lab feedback.<\/li>\n\n\n\n<li><strong>Predictive Digital Twins:<\/strong> Long-term goal includes creating <strong>dynamic digital reconstructions<\/strong> of disease progression and treatment response for precision medicine applications.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-investor-confidence-amp-market-position\">Investor Confidence &amp; Market Position<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>China Life Investment\u2019s Lead Role<\/strong> signals strong institutional trust in deep-tech biotech convergence and cross-border innovation.<\/li>\n\n\n\n<li><strong>Backed by Top-Tier VCs:<\/strong> Support from <strong>XtalPi<\/strong> (AI-driven drug discovery leader) and <strong>Legend Capital<\/strong> underscores strategic alignment with next-gen R&amp;D paradigms.<\/li>\n\n\n\n<li><strong>Competitive Differentiation:<\/strong> Xellar is among the few globally integrating <strong>physical organ models<\/strong>, <strong>mechanistic biology<\/strong>, and <strong>generative AI<\/strong> into a unified discovery engine.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding platform development, data collection, and AI capabilities. Actual outcomes depend on technical execution, regulatory compliance, and scientific validation.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Xellar Biosystems, a U.S.-based pioneer in \u201cAI + organ-on-a-chip\u201d technology, announced the successful completion of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,93],"tags":[4526],"class_list":["post-62294","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","category-digital","tag-xellar-biosystems"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Xellar Biosystems, a U.S.-based pioneer in \u201cAI + organ-on-a-chip\u201d technology, announced the successful completion of a Series A financing round exceeding RMB 200 million (\u2248 USD 29 million). The round was exclusively led by China Life Investment, with continued backing from existing investors XtalPi, Yael Capital, and Legend Capital.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=62294\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform\" \/>\n<meta property=\"og:description\" content=\"Xellar Biosystems, a U.S.-based pioneer in \u201cAI + organ-on-a-chip\u201d technology, announced the successful completion of a Series A financing round exceeding RMB 200 million (\u2248 USD 29 million). The round was exclusively led by China Life Investment, with continued backing from existing investors XtalPi, Yael Capital, and Legend Capital.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=62294\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-03T08:47:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-03T08:47:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62294#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62294\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform\",\"datePublished\":\"2026-04-03T08:47:20+00:00\",\"dateModified\":\"2026-04-03T08:47:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62294\"},\"wordCount\":336,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Xellar Biosystems\"],\"articleSection\":[\"Company\",\"Deals\",\"Digital\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62294#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62294\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=62294\",\"name\":\"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-04-03T08:47:20+00:00\",\"dateModified\":\"2026-04-03T08:47:21+00:00\",\"description\":\"Xellar Biosystems, a U.S.-based pioneer in \u201cAI + organ-on-a-chip\u201d technology, announced the successful completion of a Series A financing round exceeding RMB 200 million (\u2248 USD 29 million). The round was exclusively led by China Life Investment, with continued backing from existing investors XtalPi, Yael Capital, and Legend Capital.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62294#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62294\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62294#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform - Insight, China&#039;s Pharmaceutical Industry","description":"Xellar Biosystems, a U.S.-based pioneer in \u201cAI + organ-on-a-chip\u201d technology, announced the successful completion of a Series A financing round exceeding RMB 200 million (\u2248 USD 29 million). The round was exclusively led by China Life Investment, with continued backing from existing investors XtalPi, Yael Capital, and Legend Capital.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=62294","og_locale":"en_US","og_type":"article","og_title":"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform","og_description":"Xellar Biosystems, a U.S.-based pioneer in \u201cAI + organ-on-a-chip\u201d technology, announced the successful completion of a Series A financing round exceeding RMB 200 million (\u2248 USD 29 million). The round was exclusively led by China Life Investment, with continued backing from existing investors XtalPi, Yael Capital, and Legend Capital.","og_url":"https:\/\/flcube.com\/?p=62294","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-03T08:47:20+00:00","article_modified_time":"2026-04-03T08:47:21+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=62294#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=62294"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform","datePublished":"2026-04-03T08:47:20+00:00","dateModified":"2026-04-03T08:47:21+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=62294"},"wordCount":336,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Xellar Biosystems"],"articleSection":["Company","Deals","Digital"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=62294#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=62294","url":"https:\/\/flcube.com\/?p=62294","name":"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-04-03T08:47:20+00:00","dateModified":"2026-04-03T08:47:21+00:00","description":"Xellar Biosystems, a U.S.-based pioneer in \u201cAI + organ-on-a-chip\u201d technology, announced the successful completion of a Series A financing round exceeding RMB 200 million (\u2248 USD 29 million). The round was exclusively led by China Life Investment, with continued backing from existing investors XtalPi, Yael Capital, and Legend Capital.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=62294#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=62294"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=62294#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Xellar Biosystems Closes RMB 200M Series A Led by China Life Investment to Build 3D Bio Intelligence Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=62294"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62294\/revisions"}],"predecessor-version":[{"id":62295,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62294\/revisions\/62295"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=62294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=62294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=62294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}